USPTO Patents Application 10686801

Connecting via Winsock to STN

Welcome to STN International! Enter x:x

LOGINID : SSPTACKH1617

PASSWORD:

TERMINAL (ENTER 1, 2, 3, OR ?):2

it it It

★ *

* *

* Welcome to STN International **********

NEWS

1

Web Page URLs for STN Seminar Schedule - N. America

NEWS

2

"Ask CAS" for self-help around the clock

NEWS

3

OCT

23

The Derwent World Patents Index suite of databases on STN

has been enhanced and reloaded

NEWS

4

OCT

30

CHEMLIST enhanced with new search and display field

NEWS

5

NOV

03

JAPIO enhanced with IPC 8 features and functionality

NEWS

6

NOV

10

CA/CAplus F-Term thesaurus enhanced

NEWS

7

NOV

10

STN Express with Discover! free maintenance release Version

8.01c now available

NEWS

8

NOV

20

CA/CAplus to MARPAT accession number crossover limit increased

to 50, 000

NEWS

9

DEC

01

CAS REGISTRY updated with new ambiguity codes

NEWS

10

DEC

11

CAS REGISTRY chemical nomenclature enhanced

NEWS

11

DEC

14

WPIDS/WPINDEX/WPIX manual codes updated

NEWS

12

DEC

14

GBFULL and FRFULL enhanced with IPC 8 features and

functionality

NEWS

13

DEC

18

CA/CAplus pre- 1967 chemical substance index entries enhanced

with preparation role

NEWS

14

DEC

18

CA/CAplus patent kind codes updated

NEWS

15

DEC

18

MARPAT to CA/CAplus accession number crossover limit increased

to 50,000

NEWS

16

DEC

18

MEDLINE updated in preparation for 2007 reload

NEWS

17

DEC

27

CA/CAplus enhanced with more pre- 1907 records

NEWS

18

JAN

08

CHEMLIST enhanced with New Zealand Inventory of Chemicals

NEWS

19

JAN

16

CA/CAplus Company Name Thesaurus enhanced and reloaded

NEWS

20

JAN

16

IPC version 2007.01 thesaurus available on STN

NEWS

21

JAN

16

WPIDS/WPINDEX/WPIX enhanced with IPC 8 reclassification data

NEWS

22

JAN

22

CA/CAplus updated with revised CAS roles

NEWS

23

JAN

22

CA/CAplus enhanced with patent applications from India

NEWS

24

JAN

29

PHAR reloaded with new search and display fields

NEWS

25

JAN

29

CAS Registry Number crossover limit increased to 300,000 in

multiple databases

NEWS EXPRESS NOVEMBER 10 CURRENT WINDOWS VERSION IS V8.01C, CURRENT
MACINTOSH VERSION IS V6.0c{ENG) AND V6.0Jc(JP),
AND CURRENT DISCOVER FILE IS DATED 25 SEPTEMBER 2006.

NEWS HOURS STN Operating Hours Plus Help Desk Availability

NEWS LOGIN Welcome Banner and News Items

NEWS IPCS For general information regarding STN implementation of IPC 8

NEWS X25 X.25 communication option no longer available

Enter NEWS followed by the item number or name to see news on that
specific topic.

All use of STN is subject to the provisions of the STN Customer
agreement. Please note that this agreement limits use to scientific
research. Use for software development or design or implementation
of commercial gateways or other similar uses is prohibited and may

result in loss of user privileges and other penalties.

************** sxN Columbus ***************

FILE 'HOME* ENTERED AT 15:54:05 ON 09 FEB 2007
=> file biosis caplus embase medline scisearch

COST IN U.S. DOLLARS SINCE FILE TOTAL

ENTRY SESSION

FULL ESTIMATED COST 0.21 0.21

FILE 'BIOSIS' ENTERED AT 15:54:44 ON 09 FEB 2007
Copyright (c) 2007 The Thomson Corporation

FILE 'CAPLUS' ENTERED AT 15:54:44 ON 09 FEB 2007

USE IS SUBJECT TO THE TERMS OF YOUR STN CUSTOMER AGREEMENT.

PLEASE SEE "HELP USAGETERMS" FOR DETAILS.

COPYRIGHT (C) 2007 AMERICAN CHEMICAL SOCIETY (ACS)

FILE 'EMBASE' ENTERED AT 15:54:44 ON 09 FEB 2007
Copyright (c) 2007 Elsevier B.V. All rights reserved,

FILE 'MEDLINE' ENTERED AT 15:54:44 ON 09 FEB 2007

FILE 'SCISEARCH' ENTERED AT 15:54:44 ON 09 FEB 2007
Copyright (c) 2007 The Thomson Corporation

=> s phenolic antioxidant or oxygenated dibenzo-alpha-pyrone or DBP

LI 36483 PHENOLIC ANTIOXIDANT OR OXYGENATED DIBENZO-ALPHA-PYRONE OR DBP

=> s (phenolic with antioxidant) or (oxygenated with dibenzo-alpha-pyrone) or DBP
L2 34418 (PHENOLIC WITH ANTIOXIDANT) OR (OXYGENATED WITH D IBENZO- ALPHA- PY

RONE) OR DBP

s L2 and chromium or cr
L3 707630 L2 AND CHROMIUM OR CR

=> s L2 and (chromium or cr)

L4 323 L2 AND (CHROMIUM OR CR)

=> L4 and ( (phyllanthus with emblica) or (emblica with officinalis) )
L4 IS NOT A RECOGNIZED COMMAND

The previous command name entered was not recognized by the system.
For a list of commands available to you in the current file, enter
• "HELP COMMANDS" at an arrow prompt (=>) .

=> (phyllanthus with emblica) or (emblica with officinalis)
(PHYLLANTHUS IS NOT A RECOGNIZED COMMAND

The previous command name entered was not recognized by the system.
For a list of commands available to you in the current file, enter
"HELP COMMANDS" at an arrow prompt (=>) .

=> s (phyllanthus with emblica) or (emblica with officinalis)

L5 913 (PHYLLANTHUS WITH EMBLICA) OR (EMBLICA WITH OFFICINALIS)

=> s L4 and L5

L6 2 L4 AND L5

=> d ibib abs all

L6 ANSWER 1 OF 2 CAPLUS COPYRIGHT 2007 ACS on STN
ACCESSION NUMBER: 2005:346732 CAPLUS

DOCUMENT NUMBER: 142:386005
TITLE: Phenolic antioxidant-

chromium complexes for treatment or prevention

INVENTOR (S) :
PATENT ASSIGNEE (S) :
SOURCE :

DOCUMENT TYPE:
LT^GUAGE :

FAMILY ACC. NUM. COUNT:
PATENT INFORMATION:

of type 2 diabetes or
Ghosal, Shibnath
Natreon Inc . , Germany
U.S. Pat. Appl. Publ.
CODEN: USXXCO
Patent
English
1

glucose intolerance
12 pp.

PATENT NO.

KIND DATE

APPLICATION NO.

DATE

US 2005085454
PRIORITY APPLN. INFO.
AB

Al

20050421

US 2003-686801 20031016
US 2003-686801 20031016
A composition for the treatment, prevention or management of a condition in
primates, especially humans comprising a phenolic antioxidant
-chromium complex.
AN 2005:346732 CAPLUS
DN 142:386005

ED Entered STN: 22 Apr 2005

TI Phenolic antioxidant -chromium complexes for

treatment or prevention of type 2 diabetes or glucose intolerance
Ghosal, Shibnath

IN
PA
SO

Natrpon Inc . , Germany
U.S. Pat. Appl. Publ.
CODEN : USXXCO
Patent
English

ICM A61K031-555

ICS A61K031-28
514185000; 514505000
1-10 ( Pharmacology)
Section cross-reference (s)
FAN.CNT 1

PATENT NO. KIND

12 pp.

DT
LA
IC

INCL

cc

63

DATE

PI US 2005085454
PRAI US 2003-686801
CLASS

PATENT NO. CLASS

Al

20050421
20031016

APPLICATION NO.

US 2003-686801

DATE

20031016

PATENT FAMILY CLASSIFICATION CODES

US 2005085454 ICM A61K031-555
ICS A61K031-28
INCL 514185000; 514505000

IPCI A61K0031-555 [ICM, 7] ; A61K0031-28 [ICS, 7]

IPCR A61K0031-28 [I,C*]; A61K0031-28 [I,A] ; A61K0031-555

[I,C*]; A61K0031-555 [I, A]
NCL 514/185.000; 514/505.000

ECLA A61K031/28; A61K031/555; A61K033/24; A61K035/78
AB A composition for the treatment, prevention or management of a condition in

primates, especially humans comprising a phenolic antioxidant

-chromium complex.
ST phenolic plant antioxidant chromium complex

oral antidiabetic; Shilajit phenolic antioxidant

chromium complex oral antidiabetic
IT Natural products, pharmaceutical

RL: PAC (Pharmacological activity) ; THU (Therapeutic use) ; BIOL

(Biological study) ; USES (Uses)

(Shilajit; phenolic antioxidant -chromium

complexes for treatment or prevention of type 2 diabetes or glucose
intolerance)
IT Diabetes mellitus

( non- insulin- dependent ; phenolic antioxidant-

chromium complexes for treatment or prevention of type 2

diabetes or glucose intolerance)

IT Antidiabetic agents

(oral; phenolic antioxidant -chromium

complexes for treatment or prevention of type 2 diabetes or glucose
intolerance)
IT Antioxidants
Erodium

Erodium pelargonif lorum
Gardenia
Geranium (genus)
Geranium thunbergii
Human

Phyllanthus

Phyllanthus emblica
Phyllanthus flexuosus
Phyllanthus niruri
Tamarix

Tamarix aphylla
Terminalia

Terminalia bellirica

(phenolic antioxidant -chromium complexes

for treatment or prevention of type 2 diabetes or glucose intolerance)
IT Fulvic acids

Phenols, biological studies
Tannins

RL: PAC (Pharmacological activity); THU (Therapeutic use); BIOL
(Biological study) ; USES (Uses)

(phenolic antioxidant -chromium complexes

for treatment or prevention of type 2 diabetes or glucose intolerance)
IT 50-99-7, Glucose, biological studies

RL: BSU (Biological study, unclassified) ; BIOL (Biological study)
(intolerance; phenolic antioxidant -chromium

complexes for treatment or prevention of type 2 diabetes or glucose
intolerance)

IT 58-85-5, Biotin 59-43-8, biological studies 79-17-4, Ami noguani dine
616-91-1, N-Acetyl-L- cysteine 1066-30-4, Chromium acetate
7440-47-3, Chromium, biological studies 10025-73-7,
Chromium chloride (CrC13) 16065-83- ID, Chromium 3+,
complexes, biological studies 27115-36-2, Chromium formate
59715-47-8D, DBP, chromium complexes 64452-96-6,
Chromium nicotinate

RL: PAC (Pharmacological activity) ; THU (Therapeutic use) ; BIOL
(Biological study) ; USES (Uses)

(phenolic antioxidant -chromium complexes

for treatment or prevention of type 2 diabetes or glucose intolerance)

=> d his

(FILE 'HOME' ENTERED AT 15:54:05 ON 09 FEB 2007)

FILE 'BIOSIS, CAPLUS, EMBASE, MEDLINE, SCISEARCH' ENTERED AT 15:54:44 ON
09 FEB 2007

LI 36483 S PHENOLIC ANTIOXIDANT OR OXYGENATED DIBENZO - ALPHA- PYRONE OR DB

L2 34418 S (PHENOLIC WITH ANTIOXIDANT) OR (OXYGENATED WITH DIBENZO- TOjPHA

L3 707630 S L2 AND CHROMIUM OR CR

L4 323 S L2 AND (CHROMIUM OR CR)

L5 913 S (PHYLLANTHUS WITH EMBLICA) OR (EMBLICA WITH OFFICINALIS)

L6 2 S L4 AND L5

= >

--Logging off of STN--

= >

Executing the logoff script.

=> LOG Y

COST IN U.S. DOLLARS
FULL ESTIMATED COST

DISCOUNT AMOUNTS (FOR QUALIFYING ACCOUNTS)
CA SUBSCRIBER PRICE
STN INTERNATIONAL LOGOFF AT 16:01:12 ON 09 FEB 2007

SINCE FILE
ENTRY
61.74

SINCE FILE
ENTRY
-0.78

TOTAL
SESSION
61.95

TOTAL
SESSION
-0.78